Saturday, July 11, 2026

pharma · COPD (Chronic Obstructive Pulmonary Disease) · Uncontrolled Asthma

Chiesi Farmaceutici S.p.A

Chiesi Farmaceutici S.p.A trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Parma, IT HQ
6,080 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Parma, IT
Employees
6,080
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Trials

Chiesi Farmaceutici S.p.A clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Chiesi Farmaceutici S.p.A programs — each row shows trial ID, program name, phase, status, and indication.

Chiesi Farmaceutici S.p.A trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Chiesi Farmaceutici S.p.A.

  1. Experimental: CHF6001 3200 μg — Phase 2

    Clinical update
  2. CHF 5993 100/6/12.5 µg — Phase 3

    Clinical update

Trial registry

2 studies